Current pharmaceutical design

Keyphrases

Publications

volume 30, number 4, 2024

Hongjin Gao, Zhengwei Chen, Buliduhong Halihaman, Lianzhan Huang, Zhen Wang, Xuansheng Ding
Network Pharmacology and In vitro Experimental Verification to Explore the Mechanism of Chaiqin Qingning Capsule in the Treatment of Pain. Current pharmaceutical design 30 (4) (2024)
Rajdeep Tyagi, Kanchan Yadav, Nitin Srivastava, Ram Sagar
Applications of Pyrrole and Pyridine-based Heterocycles in Cancer Diagnosis and Treatment. Current pharmaceutical design 30 (4) (2024)
Rajdeep Tyagi, Kanchan Yadav, Nitin Srivastava, Ram Sagar
Applications of Pyrrole and Pyridine-based Heterocycles in Cancer Diagnosis and Treatment. Current pharmaceutical design 30 (4) (2024)
Cecilia Maldonado, Raquel Peyraube, Pietro Fagiolino, Florencia Oricchio, Leticia Cuñetti, Marta Vázquez
Human Data on Pharmacokinetic Interactions of Cannabinoids: A Narrative Review. Current pharmaceutical design 30 (4) (2024)

volume 30, number 5, 2024

Asmaa E Kassab
N -Acylhydrazone Pharmacophore's Analgesic and Anti-inflammatory Profile: Recent Advancements during the Past Ten Years. Current pharmaceutical design 30 (5) (2024)
Sebastián García Menéndez, Walter Manucha
Vitamin D as a Modulator of Neuroinflammation: Implications for Brain Health. Current pharmaceutical design 30 (5) (2024)
Jafar Karami, Bahman Razi, Danyal Imani, Saeed Aslani, Mahdi Pakjoo, Mahdieh Fasihi, Keyhan Mohammadi, Amirhossein Sahebkar
Statin Therapy and Lipid Indices in Chronic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Control Trials. Current pharmaceutical design 30 (5) (2024)
Pegah Safavi, Kimia Behrouz Moghadam, Zahra Haghighi, Gordon A Ferns, Farzad Rahmani
Interplay between LncRNA/miRNA and TGF-β Signaling in the Tumorigenesis of Gynecological Cancer. Current pharmaceutical design 30 (5) (2024)
Sebastián García Menéndez, Walter Manucha
Vitamin D as a Modulator of Neuroinflammation: Implications for Brain Health. Current pharmaceutical design 30 (5) (2024)
Xianqiang Zhou, Fang Tan, Suxian Zhang, An'an Wang, Tiansong Zhang
A Strategy based on Bioinformatics and Machine Learning Algorithms Reveals Potential Mechanisms of Shelian Capsule against Hepatocellular Carcinoma. Current pharmaceutical design 30 (5) (2024)
Pegah Safavi, Kimia Behrouz Moghadam, Zahra Haghighi, Gordon A Ferns, Farzad Rahmani
Interplay between LncRNA/miRNA and TGF-β Signaling in the Tumorigenesis of Gynecological Cancer. Current pharmaceutical design 30 (5) (2024)
Jafar Karami, Bahman Razi, Danyal Imani, Saeed Aslani, Mahdi Pakjoo, Mahdieh Fasihi, Keyhan Mohammadi, Amirhossein Sahebkar
Statin Therapy and Lipid Indices in Chronic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Control Trials. Current pharmaceutical design 30 (5) (2024)

volume 30, number 6, 2024

Yang Yang, Xiaodi Yan, YueYuan Chen, Jiajia Liu, Jianhua Xue, Xiaoming Sheng, Jun Qin, Qiang Xue, Xianchen Liu
Silencing FUT4 Inhibits the Progression of Osteosarcoma through Activation of FOXO1. Current pharmaceutical design 30 (6) (2024)
Ranjit Kumar Harwansh, Hemant Bhati, Dr Rohitas Deshmukh
Recent Updates on the Therapeutics Benefits, Clinical Trials, and Novel Delivery Systems of Chlorogenic Acid for the Management of Diseases with a Special Emphasis on Ulcerative Colitis. Current pharmaceutical design 30 (6) (2024)
Andrea Salvati, Gianluca Sesso, Francesca Lenzi, Gabriele Masi, Stefano Berloffa
Efficacy of Methylphenidate for Internet Gaming Disorder and Internet Addiction in Patients with Attention-Deficit/Hyperactivity Disorder. Current pharmaceutical design 30 (6) (2024)
Ranjit Kumar Harwansh, Hemant Bhati, Dr Rohitas Deshmukh
Recent Updates on the Therapeutics Benefits, Clinical Trials, and Novel Delivery Systems of Chlorogenic Acid for the Management of Diseases with a Special Emphasis on Ulcerative Colitis. Current pharmaceutical design 30 (6) (2024)
Ashutosh Kumar, Ghanshyam Das Gupta, Sarjana Raikwar
Artificial Intelligence Technologies used for the Assessment of Pharmaceutical Excipients. Current pharmaceutical design 30 (6) (2024)
Mohit Kumar, Devesh Kumar, Shubham Singh, Shruti Chopra, Syed Mahmood, Amit Bhatia
Quality by Design Perspective for Designing Foam-based Formulation: Current State of Art. Current pharmaceutical design 30 (6) (2024)
Mohit Kumar, Devesh Kumar, Shubham Singh, Shruti Chopra, Syed Mahmood, Amit Bhatia
Quality by Design Perspective for Designing Foam-based Formulation: Current State of Art. Current pharmaceutical design 30 (6) (2024)
Wenjing Qiu, Qianle Liang, Liyi Yu, Xuan Xiao, Wangren Qiu, Weizhong Lin
LSTM-SAGDTA: Predicting Drug-target Binding Affinity with an Attention Graph Neural Network and LSTM Approach. Current pharmaceutical design 30 (6) (2024)
Yang Yang, Xiaodi Yan, YueYuan Chen, Jiajia Liu, Jianhua Xue, Xiaoming Sheng, Jun Qin, Qiang Xue, Xianchen Liu
Silencing FUT4 Inhibits the Progression of Osteosarcoma through Activation of FOXO1. Current pharmaceutical design 30 (6) (2024)
Jinyuan Geng, Guowei Zhou, Song Guo, Chaoqun Ma, Jiangfeng Ma
Underlying Mechanism of Traditional Herbal Formula Chuang-Ling-Ye in the Treatment of Diabetic Foot Ulcer through Network Pharmacology and Molecular Docking. Current pharmaceutical design 30 (6) (2024)

volume 30, number 7, 2024

Karthika Paul, Benachakal Honnegowda Jaswanth Gowda, Umme Hani, Ravandur Shivanna Chandan, Sourav Mohanto, Mohammed Gulzar Ahmed, Sumel Ashique, Prashant Kesharwani
Traditional Uses, Phytochemistry, and Pharmacological Activities of Coleus amboinicus : A Comprehensive Review. Current pharmaceutical design 30 (7) (2024)
Spyros N Deftereos, George D Vavougios, Christos Bakirtzis, George Hadjigeorgiou, Nikolaos Grigoriadis
Effects of High Efficacy Multiple Sclerosis Disease Modifying Drugs on the Immune Synapse: A Systematic Review. Current pharmaceutical design 30 (7) (2024)
Jiangxia Chen, Lijun Zhou, Qingchun Zhao, Zhentong Qi
A New Cell Model Overexpressing sTGFBR3 for Studying Alzheimer's Disease In vitro . Current pharmaceutical design 30 (7) (2024)
Michael Spartalis, Christos Kontogiannis, Eleftherios Spartalis, Dimitrios C Iliopoulos, Gerasimos Siasos
Anticoagulation in Patients with Atrial High-rate Episodes Detected by Cardiac Implantable Electronic Devices. Current pharmaceutical design 30 (7) (2024)
Ajinkya Nitin Nikam, Amrita Roy, Ruchira Raychaudhuri, Prerana D Navti, Soji Soman, Sanjay Kulkarni, Krishnaraj Somayaji Shirur, Abhijeet Pandey, Srinivas Mutalik
Organogels: "GelVolution" in Topical Drug Delivery - Present and Beyond. Current pharmaceutical design 30 (7) (2024)
Jiangxia Chen, Lijun Zhou, Qingchun Zhao, Zhentong Qi
A New Cell Model Overexpressing sTGFBR3 for Studying Alzheimer's Disease In vitro . Current pharmaceutical design 30 (7) (2024)
Karthika Paul, Benachakal Honnegowda Jaswanth Gowda, Umme Hani, Ravandur Shivanna Chandan, Sourav Mohanto, Mohammed Gulzar Ahmed, Sumel Ashique, Prashant Kesharwani
Traditional Uses, Phytochemistry, and Pharmacological Activities of Coleus amboinicus : A Comprehensive Review. Current pharmaceutical design 30 (7) (2024)
Michael Spartalis, Christos Kontogiannis, Eleftherios Spartalis, Dimitrios C Iliopoulos, Gerasimos Siasos
Anticoagulation in Patients with Atrial High-rate Episodes Detected by Cardiac Implantable Electronic Devices. Current pharmaceutical design 30 (7) (2024)
Spyros N Deftereos, George D Vavougios, Christos Bakirtzis, George Hadjigeorgiou, Nikolaos Grigoriadis
Effects of High Efficacy Multiple Sclerosis Disease Modifying Drugs on the Immune Synapse: A Systematic Review. Current pharmaceutical design 30 (7) (2024)
Ajinkya Nitin Nikam, Amrita Roy, Ruchira Raychaudhuri, Prerana D Navti, Soji Soman, Sanjay Kulkarni, Krishnaraj Somayaji Shirur, Abhijeet Pandey, Srinivas Mutalik
Organogels: "GelVolution" in Topical Drug Delivery - Present and Beyond. Current pharmaceutical design 30 (7) (2024)

volume 30, number 8, 2024

Shaimaa S Goher, Wessam S Abdrabo, Giri Babu Veerakanellore, Bahaa El-Dien M El-Gendy
2,5-Diketopiperazines (DKPs): Promising Scaffolds for Anticancer Agents. Current pharmaceutical design 30 (8) (2024)
Ozgur Karcioglu, Canan Akman, Ilknur Atnis
Efficacy and Safety Analysis of Botox Application and Iatrogenic Botulism: Panacea or Peril? Current pharmaceutical design 30 (8) (2024)
Harshita Singhai, Sunny Rathee, Sanjay Kumar Jain, Umesh Kumar Patil
The Potential of Natural Products in the Management of Cardiovascular Disease. Current pharmaceutical design 30 (8) (2024)
Shaimaa S Goher, Wessam S Abdrabo, Giri Babu Veerakanellore, Bahaa El-Dien M El-Gendy
2,5-Diketopiperazines (DKPs): Promising Scaffolds for Anticancer Agents. Current pharmaceutical design 30 (8) (2024)
Xinyan Qiu, Yulin Huang, Lin Jin, Canying Yang, Jiwei Wang
Roles of AFAP1-AS1 in Gynecology and Urogenital System. Current pharmaceutical design 30 (8) (2024)
Xinyan Qiu, Yulin Huang, Lin Jin, Canying Yang, Jiwei Wang
Roles of AFAP1-AS1 in Gynecology and Urogenital System. Current pharmaceutical design 30 (8) (2024)
Zaobin Chen, Yongda Lin, Jiali Wang, Kaijin Yao, Yina Xie, Xiutian Chen, Tianbiao Zhou
Relationship between Compound α-Ketoacid and Microinflammation in Patients with Chronic Kidney Disease. Current pharmaceutical design 30 (8) (2024)
Ozgur Karcioglu, Canan Akman, Ilknur Atnis
Efficacy and Safety Analysis of Botox Application and Iatrogenic Botulism: Panacea or Peril? Current pharmaceutical design 30 (8) (2024)
Zaobin Chen, Yongda Lin, Jiali Wang, Kaijin Yao, Yina Xie, Xiutian Chen, Tianbiao Zhou
Relationship between Compound α-Ketoacid and Microinflammation in Patients with Chronic Kidney Disease. Current pharmaceutical design 30 (8) (2024)
Jose Antonio Sorolla-Romero, Javier Navarrete-Navarro, Martinez-Sole Julia, Hector M Garcia Garcia, Jose Luis Diez-Gil, Luis Martinez-Dolz, Jorge Sanz-Sanchez
Pharmacological Considerations during Percutaneous Treatment of Heart Failure. Current pharmaceutical design 30 (8) (2024)
Jose Antonio Sorolla-Romero, Javier Navarrete-Navarro, Martinez-Sole Julia, Hector M Garcia Garcia, Jose Luis Diez-Gil, Luis Martinez-Dolz, Jorge Sanz-Sanchez
Pharmacological Considerations during Percutaneous Treatment of Heart Failure. Current pharmaceutical design 30 (8) (2024)
Harshita Singhai, Sunny Rathee, Sanjay Kumar Jain, Umesh Kumar Patil
The Potential of Natural Products in the Management of Cardiovascular Disease. Current pharmaceutical design 30 (8) (2024)

volume 30, number 9, 2024

Bing Lv, Xin Gao, Guoqiang Zeng, Hui Guo, Faping Li
Safety Profile of Paxlovid in the Treatment of COVID-19. Current pharmaceutical design 30 (9) (2024)
Minghe Lv, Rong Ding, Peizhen Ma, Yue Feng, Su Zeng, Yang Zhang, Wenhao Shen, Wenhui Guan, E Xiangyu, Hongwei Zeng, Jingping Yu
Network Pharmacology Analysis on the Mechanism of Xihuangwan in Treating Rectal Cancer and Radiation Enteritis. Current pharmaceutical design 30 (9) (2024)
Jambour-Shabestary Amir-Ata, Vardast Mohammad-Reza, Hassan Malekinejad
The Benzene-induced Hepatic Cytochrome P450 2E1 Expression and Activity are Reduced by Quercetin Administration in Mice. Current pharmaceutical design 30 (9) (2024)
Raza Ali Naqvi, Araceli Valverde, Tejabhiram Yadavalli, Fatima Ismail Bobat, Kristelle J Capistrano, Deepak Shukla, Afsar R Naqvi
Viral MicroRNAs in Herpes Simplex Virus 1 Pathobiology. Current pharmaceutical design 30 (9) (2024)
Mei Sun, Feng Lv, Chunmeng Qin, Dan Du, Wenjun Li, Songqing Liu
The Potential Mechanism of Liujunzi Decoction in the Treatment of Breast Cancer based on Network Pharmacology and Molecular Docking Technology. Current pharmaceutical design 30 (9) (2024)
Raza Ali Naqvi, Araceli Valverde, Tejabhiram Yadavalli, Fatima Ismail Bobat, Kristelle J Capistrano, Deepak Shukla, Afsar R Naqvi
Viral MicroRNAs in Herpes Simplex Virus 1 Pathobiology. Current pharmaceutical design 30 (9) (2024)